Opus Genetics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-13.5M | $16.4M |
| FY2021 | — | $22.2M | $24.5M |
| FY2022 | — | $46.2M | $42.6M |
| FY2023 | — | $49.9M | $50.5M |
| FY2024 | $0 | $6.7M | $30.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-13.5M | $16.4M |
| FY2021 | — | $22.2M | $24.5M |
| FY2022 | — | $46.2M | $42.6M |
| FY2023 | — | $49.9M | $50.5M |
| FY2024 | $0 | $6.7M | $30.3M |